Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
|
664.7000 2.00 (0.30%)
NSE Dec 31, 2025 11:44 AM
Volume: 19,629
 

664.70
0.30%

Outperformance across metrics; stellar start to the post-IPO phase

Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
Rubicon Research Ltd. is trading above all available SMAs
More from Rubicon Research Ltd.
Recommended